Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)

NCT01031992 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Hereditary Hemorrhagic Telangiectasia

Interventions

DRUG: Tranexamic acid first, than placebo
DRUG: First placebo, than Tranexamic acid.

Sponsor

University Hospital, Saarland

Collaborators

[object Object]
[object Object]